Company ProfilePremium

Organovo Holdings Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Organovo Holdings Inc. - Healthcare showcase

Year Founded & Workforce

2007

115 Employees

Industry

Healthcare

Services

Tissues and Services
O

Organovo Holdings Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Organovo Holdings Inc. Overview

Company Headquarters: San Diego, US

Founded: 2007

Workforce: 115+

Company Working: Organovo Holdings Inc. is a leading biotechnology company which provides 3D bioprinting functional tissues. The company focuses on manufacturing three-dimensional tissues, and these tissues are used in various research and development activities as well as in implant therapies. Moreover, it depends on collaborations and strategic agreements with biopharmaceutical companies, research institutes, and healthcare providers to expand its business. Organovo Holdings Inc. provides products and services related to therapeutic tissues, high-quality human cells (samsara), and disease modeling platform that supports drug discovery and development.

Strategy

Organovo Holdings Inc. focuses on expanding its business in emerging markets by providing innovative products. It focuses on designing, developing, and validating more predictive tissues for research and development. Moreover, it emphasizes on collaborative activities and collaborations to expand its geographical boundaries.

Company Snapshot

$1.4M

Revenue

115

Employees

2007

Founded

San Diego, US

Headquarters

SWOT Analysis

Strengths

  • Strong R&D pipeline
  • Innovative products
  • New product approvals

Weaknesses

  • Portfolio limited to kidney and liver tissues
  • Limited presence outside the US

Opportunities

  • Enhancing the product portfolio by launching new products
  • Collaborations with research institutes and biopharmaceutical companies to expand geographical boundaries

Threats

  • Stringent government regulations
  • High R&D expenses

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Organovo Holdings Inc.
    • Tissues and Services

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 1.4 Mn in 2016 to USD 4.6 Mn in 2018.
Organovo Holdings Inc. — By Business Segment
Series (USD Mn)201620172018
Sales1.44.24.6
R&D Expenditure1819.518.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.